Northwest Biotherapeutics
(OTC) NWBO
Northwest Biotherapeutics Financials at a Glance
Market Cap
$304.02M
Revenue (TTM)
$1.50M
Net Income (TTM)
-$43.89M
EPS (TTM)
-$0.03
P/E Ratio
-6.05
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$0.19
Volume
1,651,673
Open
$0.18
Price
$0.19
Volume
1,651,673
Open
$0.18
Previous Close
$0.19
Daily Range
$0.18 - $0.19
52-Week Range
$0.18 - $0.37
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.06 (Low)
Price
$0.19
Volume
1,651,673
Open
$0.18
Previous Close
$0.19
Daily Range
$0.18 - $0.19
52-Week Range
$0.18 - $0.37
Estimated Earnings Date
Aug 13, 2026
NWBO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Northwest Biotherapeutics
Industry
Biotechnology
Sector
Health CareEmployees
25
CEO
Linda F. Powers
Website
www.nwbio.comHeadquarters
Bethesda, MD 20814, US
NWBO Financials
Key Financial Metrics (TTM)
Gross Margin
-44.89%
Operating Margin
-3574.01%
Net Income Margin
-2931.73%
Return on Equity
62.41%
Return on Capital
-347.19%
Return on Assets
-54.83%
Earnings Yield
-16.53%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$304.02M
Shares Outstanding
1.64B
Volume
1.65M
Avg. Volume
3.21M
Financials (TTM)
Gross Profit
-$672.00K
Operating Income
-$53.50M
EBITDA
-$59.83M
Operating Cash Flow
-$47.85M
Capital Expenditure
-$433.00K
Free Cash Flow
-$48.29M
Cash & ST Invst.
$1.79M
Total Debt
$63.99M
Northwest Biotherapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$494.00K
+31.7%
Gross Profit
-$353.00K
-194.1%
Gross Margin
-71.46%
N/A
Market Cap
$304.02M
N/A
Market Cap/Employee
$12.16M
N/A
Employees
25
N/A
Net Income
-$3.07M
+84.3%
EBITDA
-$10.05M
+41.9%
Quarterly Fundamentals
Total Cash
$1.79M
-35.7%
Total Debt
$63.99M
-7.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$20.50M
-16.6%
Short Term Debt
$43.77M
-1.5%
Return on Assets
-54.83%
N/A
Return on Invested Capital
18.31%
N/A
Free Cash Flow
-$12.64M
-34.2%
Operating Cash Flow
-$12.51M
-32.8%